BAJAJ BROKING

Notification
No new Notification messages
One Mobikwik Systems IPO is Open!
Apply for the One Mobikwik Systems IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
pharmaids pharmaceuticals ltd. stock

PHARMAIDS PHARMACEUTICALS LTD. Share Price

55.73 2.64 (4.97%)
Dec 11 2024 02:58 PM Pharmaceuticals NSE: PHARMAID

PHARMAIDS PHARMACEUTICALS LTD. Share Price Update

As of the latest trading session, PHARMAIDS PHARMACEUTICALS LTD. share price is currently at 55.73, which is up by 2.64 from its previous closing. Today, the stock has fluctuated between 53.00 and 55.73. Over the past year, PHARMAIDS PHARMACEUTICALS LTD. has achieved a return of 39.86 %. In the last month alone, the return has been -33.09 %. Read More...

PHARMAIDS PHARMACEUTICALS LTD. Performance

Day Range

Low53.00 High55.73
55.73

52 Week Range

Low 31.90 High 87.46
55.73

PHARMAIDS PHARMACEUTICALS LTD. Share Price

524572

PHARMAID

img img img img
No Data Available

Open Price

55.65

Prev. Close

53.08

Volume (Shares)

42109.00

Total traded value

23.46

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

PHARMAIDS PHARMACEUTICALS LTD. Fundamentals


(Standalone)

Market Cap (Cr) 196.54
PE Ratio (TTM) -28.85
Book Value / Share 19.40
Beta -0.24
ROE 0.00%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) -1.01

PHARMAIDS PHARMACEUTICALS LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 0.03
Operating Expense 6.91
Net Profit -4.95
Net Profit Margin (%) -16500.00
Earnings Per Share (EPS) -2.18
EBITDA -5.58
Effective Tax Rate (%) 18.71
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 9.91
Net Profit -7.56
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -5.86
EBITDA -9.89
Effective Tax Rate (%) 23.71
Particulars MAR 2022 (Values in Cr)
Revenue 3.94
Operating Expense 3.81
Net Profit 0.15
Net Profit Margin (%) 3.80
Earnings Per Share (EPS) 0.14
EBITDA 0.15
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 8.55
Operating Expense 8.49
Net Profit 0.09
Net Profit Margin (%) 1.05
Earnings Per Share (EPS) 0.09
EBITDA 0.13
Effective Tax Rate (%) 0.00
Particulars MAR 2020 (Values in Cr)
Revenue 0.00
Operating Expense 0.37
Net Profit 0.03
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.03
EBITDA -0.34
Effective Tax Rate (%) 107.89
Particulars MAR 2024 (Values in Cr)
Book Value / Share 20.43
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.09
EBITDA Margin -81.54
Particulars MAR 2023 (Values in Cr)
Book Value / Share 10.31
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 8.44
ROE % 1.36
ROCE % 1.36
Total Debt to Total Equity 0.00
EBITDA Margin 3.81
Particulars MAR 2024 (Values in Cr)
Book Value / Share 20.15
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.14
EBITDA Margin -18600.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 10.46
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 8.44
ROE % 1.36
ROCE % 1.36
Total Debt to Total Equity 0.00
EBITDA Margin 3.81
Particulars MAR 2021 (Values in Cr)
Book Value / Share 8.30
ROE % 0.82
ROCE % 0.82
Total Debt to Total Equity 0.00
EBITDA Margin 1.52
Particulars MAR 2020 (Values in Cr)
Book Value / Share 8.21
ROE % 0.31
ROCE % -3.92
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 4.80
Total Assets 91.34
Total Liabilities 91.34
Total Equity 70.49
Share Outstanding 35267812
Price to Book Ratio 2.58
Return on Assets (%) -8.72
Return on Capital (%) -10.51
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 12.75
Total Assets 24.58
Total Liabilities 24.58
Total Equity 22.46
Share Outstanding 214862340
Price to Book Ratio 2.09
Return on Assets (%) -30.73
Return on Capital (%) -33.64
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.40
Total Assets 11.11
Total Liabilities 11.11
Total Equity 8.67
Share Outstanding 21486234
Price to Book Ratio 1.48
Return on Assets (%) 1.30
Return on Capital (%) 1.67
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.45
Total Assets 85.00
Total Liabilities 85.00
Total Equity 71.06
Share Outstanding 35267812
Price to Book Ratio 2.58
Return on Assets (%) -5.82
Return on Capital (%) -5.92
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 12.75
Total Assets 24.54
Total Liabilities 24.54
Total Equity 22.42
Share Outstanding 21486234
Price to Book Ratio 2.09
Return on Assets (%) -30.77
Return on Capital (%) -33.69
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.40
Total Assets 11.11
Total Liabilities 11.11
Total Equity 8.67
Share Outstanding 10268819
Price to Book Ratio 1.48
Return on Assets (%) 1.30
Return on Capital (%) 1.67
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.20
Total Assets 9.11
Total Liabilities 9.11
Total Equity 8.52
Share Outstanding 10268819
Price to Book Ratio 1.35
Return on Assets (%) 1.02
Return on Capital (%) 1.09
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 8.45
Total Liabilities 8.45
Total Equity 8.43
Share Outstanding 10268819
Price to Book Ratio 0.55
Return on Assets (%) 0.39
Return on Capital (%) 0.4
Particulars MAR 2024 (Values in Cr)
Net Income -15.62
Cash from Operations -10.61
Cash from Investing -74.99
Cash from Financing 77.65
Net change in Cash -7.95
Free Cash Flow 12.24
Particulars MAR 2023 (Values in Cr)
Net Income -9.90
Cash from Operations -4.01
Cash from Investing -4.94
Cash from Financing 21.30
Net change in Cash 12.34
Free Cash Flow -2.34
Particulars MAR 2022 (Values in Cr)
Net Income 0.14
Cash from Operations -0.25
Cash from Investing 0.46
Cash from Financing 0.00
Net change in Cash 0.20
Free Cash Flow -0.25
Particulars MAR 2024 (Values in Cr)
Net Income -6.08
Cash from Operations -3.44
Cash from Investing -72.50
Cash from Financing 65.66
Net change in Cash -10.29
Free Cash Flow 12.92
Particulars MAR 2023 (Values in Cr)
Net Income -9.90
Cash from Operations -4.01
Cash from Investing -4.94
Cash from Financing 21.31
Net change in Cash 12.35
Free Cash Flow -2.34
Particulars MAR 2022 (Values in Cr)
Net Income 0.14
Cash from Operations -0.25
Cash from Investing 0.46
Cash from Financing 0.00
Net change in Cash 0.20
Free Cash Flow -0.25
Particulars MAR 2021 (Values in Cr)
Net Income 0.08
Cash from Operations 0.40
Cash from Investing -0.22
Cash from Financing 0.00
Net change in Cash 0.17
Free Cash Flow 0.40
Particulars MAR 2020 (Values in Cr)
Net Income -0.37
Cash from Operations -0.75
Cash from Investing 0.66
Cash from Financing 0.00
Net change in Cash -0.08
Free Cash Flow -0.70
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.90 37.87 3.59 505.01 37.54 / 77.70
BLISS GVS PHARMA LTD 155.50 19.46 1.62 1637.91 92.25 / 172.40
CIPLA LTD 1455.65 25.47 4.14 117560.12 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 414.95 144.08 4.20 1221.24 145.00 / 440.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.90 57.30 11.20 505.01 37.54 / 77.70
AMRUTAJAN HEALTH LTD 753.60 45.84 7.31 2178.71 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6634.15 128.84 24.41 16585.38 4050.15 / 8139.85
BLISS GVS PHARMA LTD 155.50 20.27 1.59 1637.91 92.25 / 172.40

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 57.60
  • 26 Days 63.80
  • 10 Days 61.60
  • 50 Days 57.20
  • 12 Days 62.60
  • 100 Days 52.80
  • 20 Days 66.50
  • 200 Days 51.70
54.42
PIVOT
First Resistance 56.50
Second Resistance 59.92
Third Resistance 62.00
First Support 51.00
Second Support 48.92
Third Support 45.50
RSI 37.66
MACD -1.13
Commodity Channel Index (CCI) -165.21
ADX 45.96
Williams % R -97.20

Over 1 Month

down

-33.09

Over 3 Months

down

36.13

Over 6 Months

down

-1.28

Over 1 Year

down

39.86

Over 3 Years

down

57.17

Over 5 Years

down

60.78

PHARMAIDS PHARMACEUTICALS LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

PHARMAIDS PHARMACEUTICALS LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
94.8
Promoter Holdings
5.19
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Shreedhara Shetty Public Shareholding 6594446.0 18.7
Shankarappa Nagaraja Vinaya Babu Public Shareholding 5200000.0 14.74
Gokaram Ramkrishna Balaji Public Shareholding 3195815.0 9.06
Asian Hotels Public Shareholding 2722258.0 7.72
Tumkur Trade Center Pvt Ltd Public Shareholding 1568000.0 4.45
Sadhanala Venkata Rao Shareholding of Promoter and Promoter Group 1550526.0 4.4
Narasandra Basavarajappa Pradeepkumar Public Shareholding 1125000.0 3.19
Venu Madhava Kaparthy Public Shareholding 876300.0 2.48
Sukhil S Mirji Public Shareholding 795854.0 2.26
Makam Sreevalli Public Shareholding 780242.0 2.21
Balagangadhara B C Public Shareholding 650000.0 1.84
Mini Manikantan Public Shareholding 500000.0 1.42
Venkatesh Mahendra Public Shareholding 438897.0 1.24
S Prasad Public Shareholding 425201.0 1.21
Govindaraja Setty Srinivasa Mithra Public Shareholding 369910.0 1.05
Padmaja Kalyani Sadhanala Shareholding of Promoter and Promoter Group 189146.0 0.54
Pilli Meena Kumari Shareholding of Promoter and Promoter Group 56000.0 0.16
Viswa Prasad Sadhanala Shareholding of Promoter and Promoter Group 19153.0 0.05
Kant Rao Shareholding of Promoter and Promoter Group 7300.0 0.02
B. Venkatswamy Shareholding of Promoter and Promoter Group 6070.0 0.02
Uttam P Jain Shareholding of Promoter and Promoter Group 1000.0 0.0
Sureshkumar Shareholding of Promoter and Promoter Group 0.0 0.0
Surekha Prashant Dave Shareholding of Promoter and Promoter Group 700.0 0.0
Baghi Rao Pankaj Sadhanala Shareholding of Promoter and Promoter Group 25.0 0.0
Maharani Maheshwari Sadhanala Shareholding of Promoter and Promoter Group 25.0 0.0
Dadi Urmila Shareholding of Promoter and Promoter Group 25.0 0.0
Sadhanalla Dara Kalyani Shareholding of Promoter and Promoter Group 1000.0 0.0
Rangoori Kantham Shareholding of Promoter and Promoter Group 1000.0 0.0

PHARMAIDS PHARMACEUTICALS LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About PHARMAIDS PHARMACEUTICALS LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by PHARMAIDS PHARMACEUTICALS LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Pharmaids Pharmaceuticals Ltd?

Answer Field

The share price of Pharmaids Pharmaceuticals Ltd for NSE is ₹ 0.00 and for BSE is ₹ 55.73.

What is the Market Cap of Pharmaids Pharmaceuticals Ltd?

Answer Field

The market cap of Pharmaids Pharmaceuticals Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 1,96.50 Cr. as of now.

What is the 52 Week High and Low of Pharmaids Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Pharmaids Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 87.46 and ₹ 31.90.

How to Buy Pharmaids Pharmaceuticals Ltd share?

Answer Field

You can trade in Pharmaids Pharmaceuticals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Pharmaids Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 39.86%.

What is the Current Share Price of Pharmaids Pharmaceuticals Ltd?

Answer Field

Pharmaids Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 55.73 as on Dec 11 2024 02:58 PM.

What is the Market Cap of Pharmaids Pharmaceuticals Ltd Share?

Answer Field

The market cap of Pharmaids Pharmaceuticals Ltd for NSE ₹ 0.0 & for BSE ₹ 1,96.50 as on Dec 11 2024 02:58 PM.

What is the P/E Ratio of Pharmaids Pharmaceuticals Ltd Share?

Answer Field

As on Dec 11 2024 02:58 PM the price-to-earnings (PE) ratio for Pharmaids Pharmaceuticals Ltd share is -28.85.

What is the PB ratio of Pharmaids Pharmaceuticals Ltd Share?

Answer Field

As on Dec 11 2024 02:58 PM, the price-to-book (PB) ratio for Pharmaids Pharmaceuticals Ltd share is 19.40.

How to Buy Pharmaids Pharmaceuticals Ltd Share?

Answer Field

You can trade in Pharmaids Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Pharmaids Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Pharmaids Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Pharmaids Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader